GENF — Genflow Biosciences Balance Sheet
0.000.00%
Last trade - 00:00- £7.87m
- £7.18m
Annual balance sheet for Genflow Biosciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.177 | 0.224 | 2.36 | 0.684 |
| Net Total Receivables | 0 | 0.02 | 0.127 | 0.343 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.18 | 0.277 | 2.62 | 1.07 |
| Net Property, Plant And Equipment | — | — | 0.002 | 0.003 |
| Total Assets | 0.18 | 0.277 | 2.62 | 1.07 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.031 | 0.221 | 0.251 | 0.346 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.031 | 0.221 | 0.251 | 0.346 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 0.149 | 0.055 | 2.37 | 0.726 |
| Total Liabilities & Shareholders' Equity | 0.18 | 0.277 | 2.62 | 1.07 |
| Total Common Shares Outstanding |